Applied Depreciation Amortization and Accretion vs Issuance Repayment of Debt Securities Analysis
APDN Stock | USD 4.78 0.00 0.00% |
Trend analysis of Applied DNA Sciences balance sheet accounts such as Total Stockholder Equity of 6 M, Accounts Payable of 921.1 K or Common Stock Total Equity of 4.4 K provides information on Applied DNA's total assets, liabilities, and equity, which is the actual value of Applied DNA Sciences to its prevalent stockholders. By breaking down trends over time using Applied DNA balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Applied |
About Applied Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Applied DNA Sciences at a specified time, usually calculated after every quarter, six months, or one year. Applied DNA Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Applied DNA and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Applied currently owns. An asset can also be divided into two categories, current and non-current.
Applied DNA Balance Sheet Chart
Applied DNA Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Applied DNA Sciences uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Applied DNA's Other Current Liabilities is very stable compared to the past year. As of the 25th of April 2024, Total Assets is likely to grow to about 16.5 M, though Retained Earnings are likely to grow to (258.6 M). Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Applied DNA balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Applied DNA Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Applied DNA obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Applied DNA Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Applied DNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied DNA Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. As of the 25th of April 2024, Selling General Administrative is likely to drop to about 10 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 10.3 M
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 18.2M | 13.4M | 15.4M | 16.1M | Research Development | 3.9M | 3.7M | 4.3M | 4.5M |
Applied DNA fundamental ratios Correlations
Click cells to compare fundamentals
Applied DNA Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied DNA fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Current Liabilities | 4.3M | 3.3M | 4.2M | 2.8M | 3.3M | 3.9M | |
Total Stockholder Equity | 5.7M | 11.1M | 12.9M | 5.0M | 5.7M | 6.0M | |
Retained Earnings | (269.8M) | (284.1M) | (292.5M) | (302.4M) | (272.2M) | (258.6M) | |
Accounts Payable | 1.3M | 2.0M | 1.7M | 1.1M | 1.2M | 921.1K | |
Common Stock Shares Outstanding | 3.9M | 6.9M | 9.0M | 13.1M | 15.0M | 15.8M | |
Non Current Liabilities Total | 1.4M | 31.5K | 5.2M | 5.9M | 6.8M | 7.2M | |
Other Stockholder Equity | 275.5M | 295.2M | 305.4M | 307.4M | 353.5M | 371.2M | |
Total Liab | 5.6M | 3.3M | 9.4M | 8.8M | 10.1M | 10.6M | |
Common Stock | 5.1K | 7.5K | 12.9K | 13.7K | 12.3K | 11.7K | |
Other Current Liab | 676.4K | 980.9K | 1.9M | 1.2M | 1.1M | 1.1M | |
Total Assets | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Net Debt | (5.4M) | (6.6M) | (15.2M) | (5.9M) | (5.3M) | (5.1M) | |
Cash | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Cash And Short Term Investments | 7.8M | 6.6M | 15.2M | 7.2M | 8.2M | 8.6M | |
Liabilities And Stockholders Equity | 11.3M | 14.4M | 22.3M | 13.7M | 15.7M | 16.5M | |
Total Current Assets | 9.1M | 11.3M | 19.9M | 8.1M | 9.3M | 5.0M | |
Non Current Assets Total | 2.3M | 3.1M | 2.3M | 5.5M | 6.4M | 6.7M | |
Intangible Assets | 864.2K | 734.8K | 605.3K | 2.7M | 2.4M | 2.6M | |
Property Plant And Equipment Net | 1.3M | 3.0M | 2.2M | 2.1M | 2.4M | 2.5M | |
Current Deferred Revenue | 511.0K | 281K | 563.6K | 76.4K | 68.8K | 65.4K | |
Non Currrent Assets Other | 95.1K | 95.0K | 99.0K | 750K | 862.5K | 905.6K | |
Property Plant And Equipment Gross | 1.3M | 3.8M | 4.3M | 5.5M | 6.3M | 6.6M | |
Net Receivables | 194.3K | 2.8M | 3.1M | 255.5K | 293.8K | 279.1K | |
Other Current Assets | 599.3K | 568.9K | 1.1M | 389.2K | 447.6K | 373.6K | |
Net Tangible Assets | (1.9M) | 4.8M | 11.1M | 12.9M | 14.8M | 15.6M | |
Property Plant Equipment | 226.2K | 1.3M | 3.0M | 2.2M | 2.6M | 2.7M | |
Other Assets | 172.0K | 95.1K | 95.0K | 99.0K | 89.1K | 84.6K | |
Inventory | 497.4K | 1.4M | 602.2K | 330.0K | 379.5K | 347.2K | |
Other Liab | 622.0K | 848.3K | 31.5K | 5.2M | 5.9M | 6.2M |
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving together with Applied Stock
0.7 | KN | Knowles Cor Earnings Call This Week | PairCorr |
0.8 | DZSI | DZS Inc Financial Report 13th of May 2024 | PairCorr |
0.67 | ITI | Iteris Inc Financial Report 11th of June 2024 | PairCorr |
0.72 | LPL | LG Display Financial Report 20th of May 2024 | PairCorr |
Moving against Applied Stock
0.47 | ITRN | Ituran Location | PairCorr |
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Applied Stock analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.678 | Quarterly Revenue Growth (0.83) | Return On Assets (0.56) | Return On Equity (1.10) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.